Hypertrophic And Keloid Scar Treatment Market Report 2026

Hypertrophic And Keloid Scar Treatment Market Overview

• Hypertrophic And Keloid Scar Treatment market size has reached to $8.49 billion in 2025 • Expected to grow to $13.77 billion in 2030 at a compound annual growth rate (CAGR) of 10.2% • Growth Driver: Rising Road Accidents And Burn Cases Fuel Growth In Hypertrophic And Keloid Scar Treatment Market • Market Trend: Clinically Proven Solution To Maximize Their Profits In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hypertrophic And Keloid Scar Treatment Market?

Hypertrophic and keloid scar treatment refers to the treatment of scars that do not grow beyond the boundaries of the original wound and spread to the surrounding skin. The hypertrophic scars are contained within the area of injury, while keloids spread outside the boundaries of the initial damage and do not regress. The main treatments of hypertrophic and keloid scar treatment are cryotherapy, surgical excision, pressure dressings, intralesional 5-fluorouracil, superficial X-ray, superficial X-ray, intralesional corticosteroid injection, and others. Cryotherapy refers to a medical procedure in which an extremely cold liquid or a cryoprobe is used to freeze and destroy abnormal tissue. Cryotherapy is used to destroy the core of the keloid scar while keeping the surface-level cells and tissue intact. The various products used during treatment include topical products, laser products, injectables, and others that are used to treat hypertrophic scars and keloid scars. The end-users of hypertrophic and keloid scar treatment are hospitals, clinics, and others.

What Is The Hypertrophic And Keloid Scar Treatment Market Growth Forecast?

The hypertrophic and keloid scar treatment market size is expected to see rapid growth in the next few years. It will grow to $13.77 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing preference for non-invasive scar treatments, increasing adoption of laser and radiotherapy techniques, rising awareness of early scar management, expansion of combination treatment protocols, improving access to advanced dermatology services. Major trends in the forecast period include increasing adoption of combination scar management therapies, rising demand for minimally invasive and non-surgical treatments, growing use of laser and energy-based scar revision techniques, expansion of post-surgical and preventive scar care solutions, higher focus on early intervention and long-term scar control.

Global Hypertrophic And Keloid Scar Treatment Market Segmentation

1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments 2) By Products: Topical Products, Laser Products, Injectables, Other Products 3) By Scar: Hypertrophic Scars, Keloid Scars 4) By End-Use: Hospitals, Clinics, Other End-Users Subsegments: 1) By Cryotherapy: Liquid Nitrogen Cryotherapy, Intralesional Cryotherapy 2) By Surgical Excision: Simple Excision, Excision With Skin Grafting 3) By Pressure Dressings: Elastic Bandage Pressure Dressings, Silicone Gel Pressure Dressings 4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment, Combination With Corticosteroids 5) By Superficial X-Ray: Low-Dose X-Ray Therapy, Combination X-Ray With Other Treatments 6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection, Combination With 5-Fluorouracil 7) By Other Treatments: Laser Therapy, Radiotherapy, Interferon Therapy

What Are The Drivers Of The Hypertrophic And Keloid Scar Treatment Market?

An increase in the number of road accidents and burn cases is expected to propel the growth of the hypertrophic and keloid scar treatment market going forward. Road accidents refer to an accident that occurs on the road and involves at least one vehicle and people. Road accidents and burn cases require attention and appropriate measures to prevent them and provide effective treatment. Hypertrophic and keloid scar treatments are used to treat people who are injured in road accidents by lowering the scar's height and tightness. An increase in road accidents and burn cases contributes to the growth of the hypertrophic and keloid scar treatment market. For instance, in January 2025, according to The Health Foundation, a UK-based independent organization reported that in 2023, there were 43 serious or fatal casualties per billion miles traveled by car, compared with 1,032 for cyclists and 1,914 for motorcyclists, while 92 pedestrians per million residents were killed or seriously injured. Therefore, the increase in the number of road accidents and burn cases will drive the hypertrophic and keloid scar treatment industry. Growing aesthetic procedures are expected to propel the growth of the hypertrophic and keloid scar treatment market going forward. Aesthetic procedures refer to non-invasive or minimally invasive cosmetic treatments performed to enhance a person's appearance and address cosmetic concerns. Hypertrophic and keloid scar treatment is employed in aesthetic procedures to minimize and improve the appearance of raised scars, contributing to a smoother and more aesthetically pleasing outcome. For instance, in June 2024, according to The International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization for plastic surgeons, in 2023, liposuction continued to be the leading surgical procedure, with more than 2.2 million procedures performed, maintaining its status from 2022. Following closely were breast augmentation and eyelid surgery, which experienced significant growth. Notably, eyelid surgery surged by 24%, reaching over 1.7 million procedures, while rhinoplasty increased by 21.6%, totaling 1.1 million procedures compared to the previous year. Therefore, growing aesthetic procedures are driving the hypertrophic and keloid scar treatment industry.

Key Players In The Global Hypertrophic And Keloid Scar Treatment Market

Major companies operating in the hypertrophic and keloid scar treatment market are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Biodermis, Mederma, Silagen

Global Hypertrophic And Keloid Scar Treatment Market Trends and Insights

Major companies in the hypertrophic and keloid scar treatment market are focusing on developing clinically proven solutions made from silicon, such as medical-grade silicone strips, to maximize their profits in the market. Medical-grade silicone strips are therapeutic products made from high-quality silicone material, specifically formulated to promote scar healing and reduction. For instance, in April 2023, Scar Erase, a UK-based company that provides silicone-based scar reduction therapy, launched Scar Erase silicone strips, a clinically tested and affordable solution for scar healing. Made from 3mm of medical-grade silicone, the strips aid in the treatment of various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. This silicone technology encapsulates the scar location, promoting hydration and an optimal healing environment, leading to significant reductions in scar texture, color, and height. It is designed for comfort and discretion, providing an accessible at-home scar treatment solution.

Regional Outlook

North America was the largest region in the hypertrophic and keloid scar treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hypertrophic And Keloid Scar Treatment Market?

The hypertrophic and keloid scar treatment market consist of revenues earned by entities by providing occlusive dressings, compression therapy, intralesional corticosteroid injections, cryosurgery, excision, radiation therapy, laser therapy, interferon (IFN) therapy, doxorubicin, bleomycin, and verapamil. The market value includes the value of related goods sold by the service provider or included within the service offering. The hypertrophic and keloid scar treatment market also includes sales of skin camouflage, silicon gels, and skin needling. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hypertrophic And Keloid Scar Treatment Market Report 2026?

The hypertrophic and keloid scar treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hypertrophic and keloid scar treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.